BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, July 13, 2026
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for April 24, 2025

April 24, 2025
New hires and promotions in the med-tech industry, including: Asahi Kasei.
Read More

Appointments and advancements for April 24, 2025

April 24, 2025
New hires and promotions in the biopharma industry, including: Abivax, Anavex, Antag, Aurion, Calidi, Coave, Creyon, Metriopharm, Newron, Nurexone, Plus, Secretome, Theradaptive, Zealand.
Read More

Appointments and advancements for April 23, 2025

April 23, 2025
New hires and promotions in the med-tech industry, including: Imperative Care, Microbot Medical, Perfuze, Resmed.
Read More

Appointments and advancements for April 23, 2025

April 23, 2025
New hires and promotions in the biopharma industry, including: Aeon, Cassava, Galapagos, Geovax, Halda, Piezo, Tagworks, Telix.
Read More

Appointments and advancements for April 22, 2025

April 22, 2025
New hires and promotions in the med-tech industry, including: Fujifil, Harbinger Health, Nanodrops.
Read More

Appointments and advancements for April 22, 2025

April 22, 2025
New hires and promotions in the biopharma industry, including: Apellis, Immunovant, Monument, Neurotech, Newamsterdam, Zymeworks.
Read More

Appointments and advancements for April 22, 2025

April 22, 2025
New hires and promotions in biopharma in Asia-Pacific, including: Chemomab, Hebe Biotechnology.
Read More

Appointments and advancements for April 21, 2025

April 21, 2025
New hires and promotions in the med-tech industry, including: Dario Health, Healthcare Integrated Technologies, Inspire Medical, Neurotech.
Read More

Appointments and advancements for April 21, 2025

April 21, 2025
New hires and promotions in the biopharma industry, including: Adicet, Bright Peak, Design, Mindimmune, Neuvogen.
Read More

Appointments and advancements for April 17, 2025

April 17, 2025
New hires and promotions in the med-tech industry, including: Cytosorbents, Terumo Blood and Cell Technologies.
Read More
Previous 1 2 … 48 49 50 51 52 53 54 55 56 … 327 328 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 10, 2026.
  • Wainua autoinjector

    Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

    BioWorld
    News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
  • Silhouette with keyhole

    FENS 2026: Next-gen biologics take on brain disease

    BioWorld
    Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • NRF2 activators reported in Vailima Peninsula patent

    BioWorld Science
    Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing